Under construction – not a live service
Sign in
Taking people in GermanyNo phase

App to track nutrition in head and neck cancer patients during and after radiotherapy

Tests a phone app tracking diet in head and neck cancer.

Plain-language title generated from the registry record
Registry title: App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy

Key facts

Where
Erlangen, GermanySee the site

Where in Germany

  • Universitätsklinikum Erlangen, StrahlenklinikErlangen, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Erlangen-Nürnberg Medical School
Trial code
NCT06367257
Record updated
31 July 2026
Original description
Patients with head and neck cancer requiring definitive or adjuvant radio(chemo)therapy can take part in the study. The aim is to record the nutritional status and diet of the patients during the trial and regularly at a period of 8 weeks after irradiation and to reduce the rate of weight loss and malnutrition.Read full original descriptionShow less

App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy

Patients with head and neck cancer requiring definitive or adjuvant radio(chemo)therapy can take part in the study. The aim is to record the nutritional status and diet of the patients during the trial and regularly at a period of 8 weeks after irradiation and to reduce the rate of weight loss and malnutrition.

Inclusion: Patients with squamous cell carcinoma in the head and neck region, who receive a postsurgical or definitive radio(chemo)therapy; Patients who have a smartphone on which the Emento app can be installed; Minimum age 18 years.

Exclusion: Patients who are represented by a legal guardian; Patients who are not suitable for participation in the study due to a language barrier.

ClinicalTrials.gov NCT06367257